目的：观察黄芪注射液辅助治疗慢性肾小球疾病的临床疗效。
Objective:To investigate the efficacy of Astragalus injection on patients with primary chronic glomerular disease.
目的探讨慢性肾小球疾病尿细胞因子改变及其与中医证型的关系。
Objective it is to discuss the urine cytokine change and the relationship between it and traditional Chinese medical syndrome type in chronic renal glomerular disease.
在任何慢性肾脏疾病，如肾小球肾炎、肾硬化或肾盂肾炎等，淋巴细胞都很常见。
It is not uncommon to see lymphocytes accompany just about any chronic renal disease: glomerulonephritis, nephrosclerosis, pyelonephritis.
慢性肾小球肾炎（CGN），是由多种病因引起的原发于肾小球的一组临床表现相似，而病理改变不一，预后不尽相同的免疫性疾病。
Chronic Glomerulonephritis (CGN), which can be caused by multiple reasons, is a series of immunological diseases with similar symptoms, different patho-manifestations and prognosises.
结果非透析CRF患者的心血管并发症的总发病率为41.51%，其中慢性肾小球肾炎CRF、高血压肾病CRF、糖尿病肾病CRF并发心血管疾病的比例分别为26.62%、6.92%和5.45%；
Results The total incidence was 41.51% in non-dialysis CRF patients, 26.62%, 6.92% and 5.45% in glomerulonephritis CRF, hypertensive CRF and diabetic CRF respectively;
结果非透析CRF患者的心血管并发症的总发病率为41.51%，其中慢性肾小球肾炎CRF、高血压肾病CRF、糖尿病肾病CRF并发心血管疾病的比例分别为26.62%、6.92%和5.45%；
Results The total incidence was 41.51% in non-dialysis CRF patients, 26.62%, 6.92% and 5.45% in glomerulonephritis CRF, hypertensive CRF and diabetic CRF respectively;
应用推荐